Pediatric centers are implanting durable adult continuous-flow ventricular assist devices
(CFVADs) in children who are smaller than the industry-recommended size. Waitlist and …

Pump thrombosis represents a significant cause of morbidity and mortality in patients on
continuous flow ventricular assist devices (CF-VAD). Pump thrombosis in the pediatric CF …

The importance of mechanical circulatory support in the therapy of advanced heart failure is
steadily growing. The rapid developments in the field of mechanical support are …

We report the implantation of a HeartWare left ventricular assist device in a child. A 9-year-
old girl presented in cardiogenic shock complicated by an embolic stroke. Catheter-based …

We report a 3-year-old boy weighing 13.5 kg who presented with intractable cardiac failure
resulting from myocarditis and was treated by implantation of a HeartWare (HVAD) device …

The use of ventricular-assist device (VAD) support continues to increase and it is now
considered part of the standard of care for most adult and children with end-stage heart …

A 10-year-old boy was admitted with dilated cardiomyopathy. Before scheduled implantation
of a HeartWare ventricular assist device, he experienced a cardiac arrest and required …

The pediatric ventricular assist device (VAD) has recently shown substantial improvements
in survival as a bridge to heart transplant for patients with end-stage heart failure. Since that …

There are many implications of improving and expanding durable device use in children.
VAD therapy is evolving as a standard of care as a bridge to transplant in children …

Despite many advances in the management of patients with heart failure, acute cardiogenic
shock and progressive congestive heart failure remain serious problems with dismal …